NCT04600193

a Randomized Controlled Trial of the Intake of Organic and Inorganic Phosphate in Peritoneal Dialysis Patients

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 21 (estimated)
• Sponsor: University of Copenhagen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Hyperphosphatemia is a common problem among patientens suffering from chronic kidney disease. Hyperphosphatemia is associated with increased risk of cardiovascular diseases. One of the treatments are through the diet, where patients are instructed ind reducing their daily intake of phosphate. But since phosphate exists in both organic and inorganic forms in the diet, this leads to several problems. Informations of the bioavability and furthermore the effect of plasma koncentrations of phosphate are lacking for both forms of phosphate.

Conditions

• Chronic Kidney Disease Requiring Chronic Dialysis

Interventions

Type	Name	Description
OTHER	Diet containing organic phosphate	The patients will be receiving a 5 days diet containing organic phosphate
OTHER	Diet containing inorganic phosphate	The patients will be receiving a 5 days diet containing inorganic phosphate

Timeline

• Start date: 2021-03-17
• Primary completion: 2021-12-31
• Completion: 2021-12-31
• First posted: 2020-10-23
• Last updated: 2021-03-18

Locations

1 site across 1 country: Denmark